Bai et al. found that miR-200c suppressed invasion of breast cancer cells by targeting ZNF217, a transcriptional activator of TGF-β, and ZEB1, and a known mediator of TGF-β signaling33. The gene discussed is ZNF217; the disease is breast cancer.